Altre lingue Zealand Pharma A/S

Azioni

ZEAL

DK0060257814

Mercato chiuso - Nasdaq Copenhagen Altri mercati azionari 16:59:46 24/05/2024			Variaz. 5gg	Var. 1 gen.
586,5 ^DKK	-2,74%		-2,25%	+57,15%

23/05	Zealand Pharma annuncia i risultati principali dello studio Dream, condotto da uno sperimentatore, con dosi ridotte del doppio agonista del recettore GLP-1/GLP-2 Dapiglutide.	CI
16/05	Transcript : Zealand Pharma A/S, Q1 2024 Earnings Call, May 16, 2024

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

El ensayo del fármaco contra la obesidad de Zealand Pharma decepciona, pero los próximos datos son clave -- Market Talk	24/05
Zealand Pharma A/S : announces topline results from the mechanistic investigator led DREAM trial with low doses of GLP 1/GLP 2 receptor dual agonist dapiglutide	23/05
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low doses of GLP-1/GLP-2 receptor dual agonist dapiglutide	23/05
Zealand Pharma Announces Topline Results from the Mechanistic Investigator-Led Dream Trial with Low Doses of GLP-1/GLP-2 Receptor Dual Agonist Dapiglutide	23/05
Nordic Stocks Declined Thursday; Zealand Pharma Took Biggest Hit	16/05
Zealand Pharma A/S : Q1 2024 Financial Results	16/05
Zealand Pharma Announces Financial Results for the First Quarter of 2024	16/05
Zealand Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	12/05
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	12/05
Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial results	09/05
Novo Nordisk y Eli Lilly caen : AmGen avanza con un medicamento contra la obesidad	03/05
Zealand Pharma A/S : Correction to Company announcement - No. 23 / 2024	19/04
Correction to Company announcement – No. 23 / 2024	19/04
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	19/04
Zealand Pharma launches long-term incentive programs for Zealand’s Board of Directors, Corporate Management and employees for 2024	19/04
U.S. Futures Up, European Stocks Flat as Powell Reiterates Room for Rate Cuts This Year	04/04
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons	26/03
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants	26/03
Zealand Pharma major shareholder announcement: Van Herk Investments	21/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Zealand Pharma A/S

Azioni

ZEAL

DK0060257814

Altre lingue

Filtri